On December 4th, GELONGHUI reported that Eryi Biological (300942.SZ) stated during an investor relations event that from a global strategy perspective, the company does not rule out enhancing competitiveness through mergers and acquisitions, bringing value-added effects to the company and creating more value for shareholders.
易瑞生物(300942.SZ)：公司未来不排除通过并购重组提升竞争力
Eryou Biotechnology (300942.SZ): The company does not rule out enhancing competitiveness through mergers and acquisitions in the future.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated